ESC 365 - Heart failure medical therapy and outcomes in patients undergoing transcatheter mitral valve repair for secondary mitral regurgitation: a TVT Registry analysis across 449 US centers

ESC Professional Premium Access

Heart failure medical therapy and outcomes in patients undergoing transcatheter mitral valve repair for secondary mitral regurgitation: a TVT Registry analysis across 449 US centers

Session: Young Investigator Awards Session in Heart Failure

Topic: Mitral Valve Regurgitation

Speaker: Doctor A. Varshney (Palo Alto, US)

Event: ESC Congress 2023

Congress Presentation

About the speaker

Doctor Anubodh Varshney

Stanford University School of Medicine, Palo Alto (United States of America)

0 follower

2 more presentations in this session

DNA methylation profiling of circulating CD4+ T cells and network analysis reveal that JUNB, SETD7, and MEF2D genes predict patients with heart failure preserved vs. reduced ejection fraction

Speaker: Doctor G. Benincasa (Naples, IT)

Polygenic risk score for hypertrophic cardiomyopathy predicts population disease risk, penetrance in sarcomeric rare variant carriers and survival in cases

Speaker: Doctor S. Zheng (London, GB)

Access the full session

Young Investigator Awards Session in Heart Failure

Speakers: Doctor A. Varshney, Doctor G. Benincasa, Doctor S. Zheng

About the event

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress

ESC 365 is supported by